Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: Results from a single institution

Abstract

Background: Intra-arterial administration of melphalan chemotherapy has shown promise in the treatment of retinoblastoma. This report describes our results using superselective intra-arterial melphalan in patients with newly diagnosed retinoblastoma and t

    Similar works